Found: 26
Select item for more details and to access through your institution.
Educational paper. The development of new therapies for pediatric oncology.
- Published in:
- 2011
- By:
- Publication type:
- journal article
DNA Damage Response−Related Proteins Are Prognostic for Outcome in Both Adult and Pediatric Acute Myelogenous Leukemia Patients: Samples from Adults and from Children Enrolled in a Children's Oncology Group Study.
- Published in:
- International Journal of Molecular Sciences, 2023, v. 24, n. 6, p. 5898, doi. 10.3390/ijms24065898
- By:
- Publication type:
- Article
Reverse Phase Protein Array Profiling Identifies Recurrent Protein Expression Patterns of DNA Damage-Related Proteins across Acute and Chronic Leukemia: Samples from Adults and the Children's Oncology Group.
- Published in:
- International Journal of Molecular Sciences, 2023, v. 24, n. 6, p. 5460, doi. 10.3390/ijms24065460
- By:
- Publication type:
- Article
The Anti-Tumor Activity of the NEDD8 Inhibitor Pevonedistat in Neuroblastoma.
- Published in:
- International Journal of Molecular Sciences, 2021, v. 22, n. 12, p. 6565, doi. 10.3390/ijms22126565
- By:
- Publication type:
- Article
Inhibition of the Sec61 translocon overcomes cytokine‐induced glucocorticoid resistance in T‐cell acute lymphoblastic leukaemia.
- Published in:
- British Journal of Haematology, 2022, v. 198, n. 1, p. 137, doi. 10.1111/bjh.18181
- By:
- Publication type:
- Article
Bortezomib reinduction chemotherapy in high‐risk ALL in first relapse: a report from the Children's Oncology Group.
- Published in:
- British Journal of Haematology, 2019, v. 186, n. 2, p. 274, doi. 10.1111/bjh.15919
- By:
- Publication type:
- Article
A phase 2 study of bortezomib in combination with ifosfamide/vinorelbine in paediatric patients and young adults with refractory/recurrent Hodgkin lymphoma: a Children's Oncology Group study.
- Published in:
- British Journal of Haematology, 2015, v. 170, n. 1, p. 118, doi. 10.1111/bjh.13388
- By:
- Publication type:
- Article
Integrin signaling is critical for myeloid-mediated support of T-cell acute lymphoblastic leukemia.
- Published in:
- Nature Communications, 2023, v. 14, n. 1, p. 1, doi. 10.1038/s41467-023-41925-z
- By:
- Publication type:
- Article
Chromatin Profiles Are Prognostic of Clinical Response to Bortezomib-Containing Chemotherapy in Pediatric Acute Myeloid Leukemia: Results from the COG AAML1031 Trial.
- Published in:
- Cancers, 2024, v. 16, n. 8, p. 1448, doi. 10.3390/cancers16081448
- By:
- Publication type:
- Article
Defining the Inflammatory Plasma Proteome in Pediatric Hodgkin Lymphoma.
- Published in:
- Cancers, 2020, v. 12, n. 12, p. 3603, doi. 10.3390/cancers12123603
- By:
- Publication type:
- Article
Glucocorticoids paradoxically facilitate steroid resistance in T cell acute lymphoblastic leukemias and thymocytes.
- Published in:
- 2020
- By:
- Publication type:
- journal article
The mitochondrial peptidase, neurolysin, regulates respiratory chain supercomplex formation and is necessary for AML viability.
- Published in:
- Science Translational Medicine, 2020, v. 12, n. 538, p. 1, doi. 10.1126/scitranslmed.aaz8264
- By:
- Publication type:
- Article
Bortezomib interactions with chemotherapy agents in acute leukemia in vitro.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2006, v. 58, n. 1, p. 13, doi. 10.1007/s00280-005-0135-z
- By:
- Publication type:
- Article
Feasibility of pevonedistat combined with azacitidine, fludarabine, cytarabine in pediatric relapsed/refractory AML: Results from COG ADVL1712.
- Published in:
- Pediatric Blood & Cancer, 2023, v. 70, n. 12, p. 1, doi. 10.1002/pbc.30672
- By:
- Publication type:
- Article
Ethnic disparities relative to disease features and outcomes in children with acute myeloid leukemia.
- Published in:
- 2017
- By:
- Publication type:
- journal article
A Phase 2 study of bortezomib combined with either idarubicin/cytarabine or cytarabine/etoposide in children with relapsed, refractory or secondary acute myeloid leukemia: A report from the Children's Oncology Group.
- Published in:
- Pediatric Blood & Cancer, 2014, v. 61, n. 10, p. 1754, doi. 10.1002/pbc.25117
- By:
- Publication type:
- Article
Novel mitochondrial DNA deletion found in a renal cell carcinoma.
- Published in:
- Genes, Chromosomes & Cancer, 1996, v. 15, n. 2, p. 95, doi. 10.1002/(SICI)1098-2264(199602)15:2<95::AID-GCC3>3.0.CO;2-Z
- By:
- Publication type:
- Article
Analysis of NF-?B Pathway Proteins in Pediatric Hodgkin Lymphoma: Correlations with EBV Status and Clinical Outcome--A Children's Oncology Group Study.
- Published in:
- Lymphoma (2090309X), 2012, p. 1, doi. 10.1155/2012/341629
- By:
- Publication type:
- Article
Proteasome subunit expression analysis and chemosensitivity in relapsed paediatric acute leukaemia patients receiving bortezomib-containing chemotherapy.
- Published in:
- Journal of Hematology & Oncology, 2016, v. 9, p. 1, doi. 10.1186/s13045-016-0312-z
- By:
- Publication type:
- Article
Population Pharmacokinetic Analysis of Bortezomib in Pediatric Leukemia Patients: Model-Based Support for Body Surface Area-Based Dosing Over the 2- to 16-Year Age Range.
- Published in:
- Journal of Clinical Pharmacology, 2017, v. 57, n. 9, p. 1183, doi. 10.1002/jcph.906
- By:
- Publication type:
- Article
AAML0523: A report from the Children's Oncology Group on the efficacy of clofarabine in combination with cytarabine in pediatric patients with recurrent acute myeloid leukemia.
- Published in:
- Cancer (0008543X), 2014, v. 120, n. 16, p. 2482, doi. 10.1002/cncr.28674
- By:
- Publication type:
- Article
A phase I trial of vorinostat and bortezomib in children with refractory or recurrent solid tumors: A Children's Oncology Group phase I consortium study (ADVL0916).
- Published in:
- Pediatric Blood & Cancer, 2013, v. 60, n. 3, p. 390, doi. 10.1002/pbc.24271
- By:
- Publication type:
- Article
Toxicity assessment of molecularly targeted drugs incorporated into multiagent chemotherapy regimens for pediatric acute lymphocytic leukemia (ALL): Review from an international consensus conference.
- Published in:
- Pediatric Blood & Cancer, 2010, v. 54, n. 7, p. 872, doi. 10.1002/pbc.22414
- By:
- Publication type:
- Article
A Phase 1 and pharmacokinetic clinical trial of paclitaxel for the treatment of refractory leukemia in children: A Children's Oncology Group study.
- Published in:
- Pediatric Blood & Cancer, 2008, v. 50, n. 4, p. 788, doi. 10.1002/pbc.21310
- By:
- Publication type:
- Article
Valosin‐containing protein (VCP/p97) is prognostically unfavorable in pediatric AML, and negatively correlates with unfolded protein response proteins IRE1 and GRP78: A report from the Children's Oncology Group.
- Published in:
- Proteomics - Clinical Applications, 2023, v. 17, n. 6, p. 1, doi. 10.1002/prca.202200109
- By:
- Publication type:
- Article
Bortezomib is significantly beneficial for de novo pediatric AML patients with low phosphorylation of the NF‐κB subunit RelA.
- Published in:
- Proteomics - Clinical Applications, 2022, v. 16, n. 2, p. 1, doi. 10.1002/prca.202100072
- By:
- Publication type:
- Article